Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenomegaly in children. Identifying the cause.

L F Odom, D G Tubergen

    Postgraduate Medicine
    |April 1, 1979
    PubMed
    Summary

    Splenomegaly, or enlarged spleen, often indicates underlying systemic disease. Diagnosis involves considering various conditions affecting spleen components, with treatment balancing spleen removal benefits against sepsis risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213.

    Leukemia·2002
    Same author

    Long-term urological complications in survivors younger than 15 months of advanced stage abdominal neuroblastoma.

    The Journal of urology·2001
    Same author

    Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting.

    Leukemia·2001
    Same author

    Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion.

    Blood·2001
    Same author

    Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia.

    Blood·1999
    Same author

    Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.

    Blood·1998

    Area of Science:

    • Internal Medicine
    • Pathology
    • Hematology

    Background:

    • Splenomegaly is frequently a manifestation of systemic diseases.
    • Enlargement of the spleen can result from abnormalities in lymphoid, reticuloendothelial, or vascular spleen components.
    • Systemic diseases causing splenomegaly can be categorized into infectious, hematologic, metabolic, vascular, and neoplastic origins.

    Purpose of the Study:

    • To outline the differential diagnosis of splenomegaly.
    • To highlight the implications of splenic enlargement.
    • To discuss the risks and benefits of splenectomy.

    Main Methods:

    • Systematic review of literature on splenomegaly.
    • Categorization of etiological factors for splenic enlargement.
    • Analysis of clinical consequences and therapeutic interventions.

    Main Results:

    • Splenomegaly is associated with increased risk of traumatic splenic rupture.
    • Splenectomy may not resolve hypersplenism and carries a risk of sepsis.
    • Diagnosis requires consideration of diverse underlying pathologies.

    Conclusions:

    • Effective management of splenomegaly necessitates accurate diagnosis of the underlying systemic disease.
    • Treatment decisions, including splenectomy, must carefully weigh potential benefits against significant risks such as sepsis.

    Related Experiment Videos